Relay Therapeutics is based out of Cambridge. Relay Therapeutics, Inc. operates as a biotechnology company. The Company develops durgs for the treatment of cancer. Relay Therapeutics serves customers in the United States. The firm last filed a Form D notice of exempt offering of securities on 2024-01-10. The notice included securities offered of Equity
Contact Info
Contact information is taken directly from publicly disclosed SEC filings.
Relay Therapeutics, Inc.399 BINNEY STREET
CAMBRIDGE MA 02139
Business Phone: 617-370-8837
SEC SIC CODE:
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)